Raptor in the News

04/01/12
NIH Study to Test Treatment for Fatty Liver Disease in Children

03/09/12
Raptor featured on ABCNews.com.

02/09/12
Fatty liver disease confronts obese youths

12/19/11
A chance for survival from a rare kidney disease

07/25/11
Raptor Orphan Drug Study Succeeds

06/01/11
Raptor hoping to spread its wings on DR Cysteamine data

05/18/11
The Significance of Raptor’s Decision to Start With Orphan Disease Strategy

04/15/11
Q&A with Ted Daley, President, Raptor Pharmaceutical Corp.

10/05/10
Raptor's DR Cysteamine: Strong Phase III trial design bodes well for approval, market uptake expected - physicians

03/17/10
Novato’s Raptor has promising breast cancer inhibitor

01/11/10
Raptor announces publication of DR Cysteamine Phase IIa results

11/23/09
Raptor Pharma's NGX426 For Pain Relief Proves Effective In Test - Update

11/23/09
Raptor Pharmaceuticals announces positive results of cysteamine bitartrate trial

10/12/09
Raptor Pharma Announces Positive Interim Phase 2a Clinical Data In Non-Alcoholic Steatohepatitis - Quick Facts

03/01/09
Twins suffer from rare disease, but research gives family hope